Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01138527Completed

Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach

Role: collaborator

NCT03922516Not ApplicableCompleted

Accuracy of Ultra-Low-Dose-CT of the Chest Compared to Plain Film in an Unfiltered Emergency Department Patient Cohort

Role: collaborator

NCT01555840Not ApplicableCompleted

Comparative Study of the Magnetically Guided Capsule Endoscopy Versus High Definition Gastroscopy

Role: collaborator

NCT01824654Not ApplicableCompleted

Enhanced Guidance for Endovascular Repair of Abdominal Aortic Aneurysm

Role: collaborator

NCT02356016Phase 2Completed

Effects of Whole-body Electromyostimulation and Dietary Supplements on "Sarcopenic Obesity"

Role: collaborator

All 5 trials loaded